Tag: biocon
Browse our exclusive articles!
Biocon arm receives tentative USFDA approval for tablets used to treat stomach ailments
Shares of Biocon Ltd. are witnessing volatile moves on Tuesday, October 7, after its wholly-owned subsidiary received tentative approval from the US Food and...
Biocon arm’s retinal disorder medication Yesafili gets public funding in Canada
Biocon Ltd's subsidiary, Biocon Biologics Ltd (BBL), announced that Yesafili (aflibercept), its biosimilar to Eylea, is now publicly funded in Ontario, Canada, for the...
Stocks to Watch: Bandhan Bank, Cochin Shipyard, Lodha Developers, Biocon & more
Key stocks in focus include Bandhan Bank, after its Yes Bank stake sale to SMBC; Cochin Shipyard, on a ₹200 crore ONGC contract; and...
Biocon Biologics gets US FDA nod for two drugs to treat osteoporosis, bone loss
Biocon Biologics Ltd, a subsidiary of Biocon Ltd, on Wednesday said it has received approval from the US Food and Drug Administration (FDA) for...
Biocon Biologics’ Bengaluru facility gets five observations from US FDA inspection
Biotechnology firm Biocon Limited on Thursday (September 4) said the US Food and Drug Administration (FDA) has completed a routine current Good Manufacturing Practice...
